6 articles in this category
Groundbreaking research reveals obesity contributes to one in ten deaths from infectious diseases worldwide, highlighting an urgent public health crisis that demands immediate attention and intervention strategies.
Arecor Therapeutics announces strategic plans to advance its innovative insulin therapy into Phase II clinical trials by 2026, following successful 2025 developments that position the company at the forefront of diabetes treatment innovation.
Groundbreaking research from Liverpool reveals that metformin, a common diabetes medication, may reduce age-related macular degeneration by 37%, offering new hope for preserving eyesight in aging populations.
Stanford Medicine researchers have achieved a groundbreaking milestone by successfully curing type 1 diabetes in mice through an innovative immune system reset using blood stem cells, offering new hope for future human treatments.
Groundbreaking research reveals a 44-metabolite blood signature that predicts type 2 diabetes risk with unprecedented accuracy, potentially transforming preventive healthcare and early intervention strategies.
Encellin's Phase 1 clinical trial reveals groundbreaking results for encapsulated islet therapy in type 1 diabetes patients, demonstrating no fibrosis and opening new possibilities for cell-based treatments.
